ESSA Pharma Inc. (EPIX) Stock Price & Growth Analysis

New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out

ESSA Pharma Inc.

EPIX

NASDAQ

Unprofitable

81M

Biotechnology

Next Earning date - 13 May 2025

81M

Biotechnology

Next Earning date - 13 May 2025

1.82USD

0.06 ( 3.41%)

Market Open

Relative Strenght

Volume Buzz

367%

Earning Acce

Dist 52w H.

77%

Overview Chart

Quote Panel

Updated April 24, 2025

1W 1.98 % 1M 16.45 % 3M 2.56 % 1Y -70.51 %

Key Metrics

Market Cap
80.79M
Shares Outstanding
44.39M
Share in Float
41.72M
Dividende
0

Earning Date
13 May 2025
Price Target
1.82
Average Volume
175106
Beta
1.613

Range
1.4-7.88
Industry
Biotechnology
Website
https://www.essapharma.com
Sector
Healthcare

Quote Panel

Updated April 24, 2025

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
Shares Outstanding
Share in Float
Dividende

Earning Date
No Data
Price Target
Average Volume
Beta

Range
Industry
Website
Sector

Fundamentals

N/A

P/E Ratio

0.00x

P/S Ratio

0.66x

P/B Ratio

0.0

Debt/Equity

0.0%

Net Margin

$-0.7

EPS

How EPIX compares to sector?

P/E Ratio

Fundamentals

Relative Strength

EPIX

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Relative Strength

EPIX

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

$0.71

-274%

2025-EPS

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Buy

Price Target

0.00(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

Piper Sandler

downgrade

Previous: Overweight

2024-11-04

Now: Neutral

Oppenheimer

downgrade

Previous: Outperform

2024-11-04

Now: Perform

Forecast

Analyst rating

Last analyst upgrade/downgrade

Earnings Growth

YoY

Current

Estimates

Q1.23

N/A

-0.16
vs -0.25

Q2.23

N/A

-0.17
vs -0.20

Q3.23

N/A

-0.12
vs -0.14

Q4.23

N/A

-0.14
vs -0.15

Q1.24

N/A

-0.20
vs -0.16

Q2.24

N/A

-0.16
vs -0.17

Q3.24

N/A

-0.14
vs -0.12

Q4.24

N/A

-0.19
vs -0.14

Q1.25

N/A

-0.19
vs -0.20

Q2.25

N/A

-0.17
vs -0.16

Sales Growth

YoY

Current

Estimates

Q3.22

NA vs NA

Q4.22

NA vs NA

Q1.23

NA vs NA

Q2.23

NA vs NA

Q3.23

NA vs NA

Q4.23

NA vs NA

Q1.24

NA vs NA

Q2.24

NA vs NA

Q3.24

NA vs NA

Q4.24

NA vs NA

Return on Equity

QoQ

Q1.23

-5%

-0.05
vs -0.04

Q2.23

-5%

-0.05
vs -0.05

Q3.23

-4%

-0.04
vs -0.05

Q4.23

-4%

-0.04
vs -0.04

Q1.24

-7%

-0.07
vs -0.04

Q2.24

-6%

-0.06
vs -0.07

Q3.24

-5%

-0.05
vs -0.06

Q4.24

-7%

-0.07
vs -0.05

Institutionnal Ownership

QoQ

Q1.23

40
vs 47

-15%

Q2.23

43
vs 40

Q3.23

39
vs 43

-9%

Q4.23

35
vs 39

-10%

Q1.24

37
vs 35

Q2.24

34
vs 37

-8%

Q3.24

35
vs 34

Q4.24

48
vs 35

37%

Earnings Growth

Latest News

accessnewswire.com

10 hours ago

EPIX DEADLINE TODAY: ROSEN, LEADING INVESTOR COUNSEL, Encourages ESSA Pharma Inc. Investors to Secure Counsel Before Important March 25 Deadline in Securities Class Action - EPIX

accessnewswire.com

10 hours ago

Investors who lost money on ESSA Pharma Inc.(EPIX) should contact Levi & Korsinsky about pending Class Action - EPIX

businesswire.com

11 hours ago

EPIX Deadline Today: Rosen Law Firm Urges ESSA Pharma Inc. (NASDAQ: EPIX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

accessnewswire.com

11 hours ago

ESSA Pharma Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your Rights - EPIX

prnewswire.com

12 hours ago

ESSA Pharma Inc. Class Action: Levi & Korsinsky Reminds ESSA Pharma Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - EPIX

accessnewswire.com

16 hours ago

Shareholders of ESSA Pharma Inc. Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your Rights - EPIX

Company Description

1.82USD

N/A

0.00x

0.66x

0.0

0.0%

$-0.7

$0.71

Earnings Growth

Latest News

Latest News

Latest News

Company Description

1.82USD

$0.71

N/A

0.00x

0.66x

0.0

0.0%

$-0.7